BioFire Defense develops and manufactures syndromic molecular technology for biothreat detection and infectious disease diagnostics. Its products are designed to deliver fast, comprehensive results in critical situations, serving sectors including biodefense, first response, government, military, and public health.
The company's product line includes the BioFire® FilmArray®, the BioFire® SPOTFIRE®, and the RAZOR® Mk II Systems. These are biological agent identification systems built for the biodefense and first responder community. BioFire Defense operates as a DCAA-audited contractor and a cGMP-compliant medical device manufacturer, maintaining rigorous quality standards across its operations.
BioFire Defense is backed by bioMérieux, a global leader in in vitro diagnostics. The company is a trusted partner for government and military facilities, with technical expertise spanning biological agent identification, biothreat detection, and CBRN detection.
